Nunzia Pharmaceutical Company (NUNZ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 21, 2026
Nunzia Pharmaceutical Company Company Description
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company.
The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders.
It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018.
Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.
Nunzia Pharmaceutical Company
| Country | United States |
| Founded | 1986 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Sara Gonzales |
Contact Details
Address: 1627 West 14th Street Long Beach, California 90813 United States | |
| Phone | 714 609 9117 |
| Website | nunziapharma.com |
Stock Details
| Ticker Symbol | NUNZ |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US67097W1027 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Sara P. Gonzales | Chief Executive Officer and Director |
| Michael Mitsunaga | President, Chief Financial Officer, Treasurer, Secretary and Director |
| Dr. Shujie Cui | Chief Medical Officer, Chief Science Officer and Director |